MSB 0.54% 92.0¢ mesoblast limited

Ann: MSB Therapy Shows Benefit In First Cohort Of RA Patients, page-8

  1. 1,300 Posts.
    lightbulb Created with Sketch. 6
    Presumably these patients had failed on Humira or something similar

    "All recruited patients are on a stable regimen of methotrexate and have previously failed or had an adverse or inadequate clinical response to at least one biologic agent."
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
92.0¢
Change
-0.005(0.54%)
Mkt cap ! $1.050B
Open High Low Value Volume
92.0¢ 92.5¢ 91.5¢ $1.133M 1.233M

Buyers (Bids)

No. Vol. Price($)
13 151980 91.5¢
 

Sellers (Offers)

Price($) Vol. No.
92.0¢ 29989 2
View Market Depth
Last trade - 16.10pm 18/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.